-
2023 SGBCC Expert Voting: HER2 Positive, BRCA Associated, Bone Modifying Therapy, Molecular Diagnosis
-
WCLC 2023 : Dr. Wu Yilong, Dr. Cheng Ying, and Dr.Han Baohui Discuss the latest advancements in Small Cell Lung Cancer Research and Analyze the Development of ADC
-
WCLC 2023 | Dr. Liu: Immunotherapy Combined Chemotherapy Can Bring Long-term Survival Benefits to ES-SCLC Patients
-
WCLC 2023 | Dr. Chen Haiquan: The Asian Perspective on Lung Cancer Screening
-
WCLC 2023 | Dr. Han Baohui’s Team Presents Multiple Research Achievements, Making China’s Voice Resonate at WCLC
-
WCLC 2023 | Dr. Shi Meiqi: Treatment Strategies for EGFR Mutation and KRAS Mutation Non-Small Cell Lung Cancer
-
WCLC Voice of China | Dr. Liang Application of Video-Based Artificial Intelligence in Thoracoscopic Lobectomy for Lung Cancer
-
WCLC Voice of China | Dr. Xie Huikang: The Value of Lepidic and Invasion Patterns New Diagnostic Criteriafor the Differential Diagnosis of AIS, MIA from Invasive Adenocarcinoma
-
WCLC 2023 |Dr. Zhu Zhengfei: SBRT Combined with Dual Immune Checkpoint Inhibitors for Advanced NSCLC Achieves a Median OS of 34 Months